The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 32,336 shares of the medical device company’s stock after selling 1,818 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Cooper Companies were worth $2,973,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the 4th quarter valued at $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies during the fourth quarter valued at $34,000. Brown Brothers Harriman & Co. grew its position in shares of Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth about $49,000. Finally, Atala Financial Inc acquired a new position in shares of Cooper Companies during the 4th quarter worth about $51,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.1 %

Shares of COO stock opened at $80.12 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The company’s 50-day moving average price is $90.45 and its 200-day moving average price is $98.44. The stock has a market cap of $16.02 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

COO has been the subject of several research reports. Citigroup cut their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird dropped their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Get Our Latest Report on COO

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Recommended Stories

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.